These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8982276)

  • 1. Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines.
    Cawston TE; Ellis AJ; Bigg H; Curry V; Lean E; Ward D
    Biochim Biophys Acta; 1996 Dec; 1314(3):226-32. PubMed ID: 8982276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture.
    Cawston TE; Ellis AJ; Humm G; Lean E; Ward D; Curry V
    Biochem Biophys Res Commun; 1995 Oct; 215(1):377-85. PubMed ID: 7575616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta1 blocks the release of collagen fragments from boving nasal cartilage stimulated by oncostatin M in combination with IL-1alpha.
    Hui W; Rowan AD; Cawston T
    Cytokine; 2000 Jun; 12(6):765-9. PubMed ID: 10843761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.
    Shingleton WD; Ellis AJ; Rowan AD; Cawston TE
    J Cell Biochem; 2000 Sep; 79(4):519-31. PubMed ID: 10996843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.
    Hui W; Rowan AD; Cawston T
    Ann Rheum Dis; 2001 Mar; 60(3):254-61. PubMed ID: 11171688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.
    Morgan TG; Rowan AD; Dickinson SC; Jones D; Hollander AP; Deehan D; Cawston TE
    Ann Rheum Dis; 2006 Feb; 65(2):184-90. PubMed ID: 15975972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of MMPs and TIMPs in cartilage turnover.
    Cawston T; Billington C; Cleaver C; Elliott S; Hui W; Koshy P; Shingleton B; Rowan A
    Ann N Y Acad Sci; 1999 Jun; 878():120-9. PubMed ID: 10415724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM; Elliott SF; Cawston TE
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
    Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
    Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.
    Cleaver CS; Rowan AD; Cawston TE
    Ann Rheum Dis; 2001 Feb; 60(2):150-7. PubMed ID: 11156549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
    Milner JM; Rowan AD; Elliott SF; Cawston TE
    Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
    Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE
    Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor.
    Ellis AJ; Curry VA; Powell EK; Cawston TE
    Biochem Biophys Res Commun; 1994 May; 201(1):94-101. PubMed ID: 8198615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
    Kozaci LD; Buttle DJ; Hollander AP
    Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
    Hui W; Rowan AD; Richards CD; Cawston TE
    Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
    Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
    Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
    Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
    Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.